ETNB
Price:
$14.84
Market Cap:
$2.20B
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Industry
Biotechnology
IPO Date
2019-11-11
Stock Exchange
NASDAQ
Ticker
ETNB
According to 89bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.11B. This represents a change of 138.01% compared to the average of 886.24M of the last 4 quarters.
The mean historical Enterprise Value of 89bio, Inc. over the last ten years is 348.37M. The current 2.11B Enterprise Value has changed 60.45% with respect to the historical average. Over the past ten years (40 quarters), ETNB's Enterprise Value was at its highest in in the June 2025 quarter at 1.46B. The Enterprise Value was at its lowest in in the September 2018 quarter at 0.
Average
348.37M
Median
293.88M
Minimum
84.11M
Maximum
730.36M
Discovering the peaks and valleys of 89bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 121.53%
Maximum Annual Enterprise Value = 730.36M
Minimum Annual Increase = -21.85%
Minimum Annual Enterprise Value = 84.11M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 730.36M | 44.36% |
| 2023 | 505.94M | 23.89% |
| 2022 | 408.38M | 77.82% |
| 2021 | 229.65M | -21.85% |
| 2020 | 293.88M | 57.73% |
| 2019 | 186.32M | 121.53% |
The current Enterprise Value of 89bio, Inc. (ETNB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
548.22M
5-year avg
433.64M
10-year avg
348.37M
89bio, Inc.’s Enterprise Value is less than ImmunityBio, Inc. (2.24B), less than Arcus Biosciences, Inc. (2.59B), less than Denali Therapeutics Inc. (2.90B), less than Cogent Biosciences, Inc. (5.53B), greater than Recursion Pharmaceuticals, Inc. (1.53B), greater than Agios Pharmaceuticals, Inc. (1.55B), greater than Galapagos N.V. (1.72B), less than Liquidia Corporation (2.94B), less than Beam Therapeutics Inc. (2.82B), greater than Ocular Therapeutix, Inc. (1.89B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.24B | $2.26B | |
| 2.59B | $2.73B | |
| 2.90B | $2.95B | |
| 5.53B | $5.60B | |
| 1.53B | $1.97B | |
| 1.55B | $1.60B | |
| 1.72B | $2.09B | |
| 2.94B | $2.90B | |
| 2.82B | $2.93B | |
| 1.89B | $2.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 89bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 89bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is 89bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for 89bio, Inc. (ETNB)?
What is the 3-year average Enterprise Value for 89bio, Inc. (ETNB)?
What is the 5-year average Enterprise Value for 89bio, Inc. (ETNB)?
How does the current Enterprise Value for 89bio, Inc. (ETNB) compare to its historical average?